JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Original Article DOI : 10.7860/JCDR/2013/7718.3777
Year : 2013 | Month : Dec | Volume : 7 | Issue : 12 Full Version Page : 2936 - 2938

Prevalence and Severity of Erectile Dysfunction as Assessed by IIEF-5 in North Indian Type 2 Diabetic Males and Its Correlation with Variables

Arvind Goyal1, Parminder Singh2, Ashish Ahuja3

1 Faculty, Department of Urology, Dayanand Medical College & Hospital, Ludhiana, Punjab India.
2 Faculty, Department of Endocrinology, Dayanand Medical College & Hospital, Ludhiana, Punjab India.
3 Faculty, Department of Surgery, Dayanand Medical College & Hospital, Ludhiana, Punjab India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Arvind Goyal, Faculty, Department of Urology, Dayanand Medical College & Hospital, Ludhiana, Punjab India.
Phone: 0161-4687305,
E-mail: drarvindgoyal@gmail.com
Abstract

Introduction: The aim of this study was to assess the severity of the erectile (ED) dysfunction among type 2 diabetic men. For subjective information patients were asked to fill up the IIEF questionnaire. This study was also done to correlate ED with other variables like age, obesity, duration of diabetes, degree of diabetic control and complications of diabetes. Neuropathy was assessed objectively by using the Vibration Perception Threshold (VPT).

Material and Methods: This study was conducted on 348 patients. Age range of these subjects was 25 years to 75 years. All patients underwent routine clinical examinations which included recording of duration of diabetes, type of diabetes, Body Mass Index, previous HbA1c tests and VPT measurement.

Results and Conclusion: In the present study, it was observed that there was a significant association of ED with age, duration of diabetes, glycemic control and BMI. In fact, VPT emerged as a strong predictor of ED. We conclude that adding objectivity of VPT measurement improves the subjective predictive value of IIEF-5.

Keywords

Introduction

Erectile Dysfunction (ED) is a common condition which is seen among men with diabetes. ED is a consistent inability of the male in achieving or sustaining an erection of sufficient rigidity, for permitting a satisfactory sexual intercourse. In diabetic men, erectile dysfunction usually occurs as a result of micro-vascular changes, neuropathy and endothelial dysfunction, which are causes of many other complications of diabetes. ED is an undiagnosed and an underreported problem. Patients tend to hide ED when they are questioned directly by their providers. Therefore, the use of validated questionnaires, those which are either self-administered in an anonymous, neutral setting or which are administered by an objective third-party interviewer, are preferred.

The aim of this study was to assess the severity of the erectile dysfunction among type 2 diabetic men who reported to diabetic clinic of a tertiary care centre. In present study, we assessed the severity of erectile dysfunction among male diabetic subjects, based upon International Index of Erectile Function (IIEF-5) questionnaire. For subjective information regarding the severity of erectile dysfunction – the patients were asked to fill up the IIEF questionnaire. Records of various medications which were taken by the patients, mainly antihypertensive drugs, cholesterol lowering drugs or any other medications, were also noted.

This study was also done to correlate ED with other variables like age, obesity, duration of diabetes, degree of diabetic control and complications of diabetes like neuropathy, nephropathy, coronary artery disease and peripheral vascular disease. Neuropathy was assessed objectively by using the Vibration Perception Threshold (VPT).

Material and Methods

This study was conducted on 348 patients of Type 2 Diabetes Mellitus, who reported for consultation. IIEF-5 is a well validated questionnaire which is used for the evaluation of sexual dysfunction and it was used to assess ED in diabetic men. After taking their informed consents, the patients were given the questionnaire and they were assisted in the form filling . Some bias occurred during answering of the questionnaire. Some patients misunderstood the meaning of an item and chose an improper answer. If this occurred, the OPD male nurse was requested to explain the meaning of each item and to help the patient in selecting the proper answer or choice.

The age range of these subjects was 25 years to 75 years. All patients underwent routine clinical examinations which included recording of duration of diabetes, type of diabetes, Body Mass Index (BMI), fasting blood sugar, previous HbA1c tests, blood pressure, cholesterol and triglycerides levels and diabetes-related complications. The frequencies and daily dosages of oral anti diabetic drugs /insulin were noted. Micro-vascular complications like retinopathy, nephropathy, and neuropathy (Reflexes and Vibration Perception Threshold studied by using DSL-Dhansai Lab Equipment), and macro-vascular complications such as heart disease, peripheral vascular disease and stroke were recorded. Drug prescriptions of hypertensive patients who were being treated and other medications were noted.

Results

The incidence of ED in our study [Table/Fig-1] was on the higher side and this may reflect actual prevalence of ED or exaggeration of sexual symptoms by patients.

Prevalence of Erectile Dysfunction in population studied

Condition of Erectile FunctionPopulation (348)
Number%
Normal Erectile Function7922.8
Erectile Dysfunction26977.2
Mild Moderate Severe12937
9126.1
4914

The most important indicator that emerged in present study was Vibration Perception Threshold (VPT), which was taken as the average VPT of left and right sides. This was compared with severity of IIEF-5 questionnaire [Table/Fig-2]. The results suggested that higher the degree of Erectile Dysfunction (ED) as measured by lower IIEF-5, higher was the VPT score, which indicated a higher degree of neurological involvement (p-value 0.00004-Significant).

Vibration Perception Threshold

Severity IIEFSevereModerateMildNormal
Severe 4933(67.5)10(20.3)6(12.2)-
Moderate 9120(21.9)38(41.7)26( 28.6)7(7.7)
Mild 12916(12.4)38(29.4)45(34.9)30(23.2)
Normal 795(6.3)11(13.9)30(38 )33(41.8)
Total 348749710770

Duration of diabetes seemed to have an important correlation with severity of ED. As the years with glycaemia increased, the prevalence of ED also increased, as was indicated in subjects with severe ED [Table/Fig-3]. Duration of diabetes had a significant correlation with ED (p-value 0.000034 -Significant).

Duration of diabetes in years as compared to severity of ED

269 out of total 348 interviewed subjects (77.3 %) had some degree of ED which ranged from mild to severe [Table/Fig-4]. A majority of subjects were in age group of 40 to 59 years (186 out of 269 I.e.69.1%). This indicated a strong correlation between age and ED. An interesting pointer was higher percentages of men in age groups of 50-59 years and 60-69 years, who suffered from severe ED, which indicated that severity increased with advancing age (p-value 0.00740-Significant).

Age groups in years

Severity IIEF20-2930-3940-4950-5960-6970-79
Severe 49-4(8.1)10(20.4)20(40.8)14(28.6)1(2)
Moderate 91-7(5.4)40(31)34(37.3)7(7.7)3(3.3)
Mild 1295(3.8)29(22.4)45(34.8)37(28.6)11(8.5)2(1.5)
Total ED 2695409591326
Normal 791(1.2)18(22.7)33(41.7)19(24)8(10)-
Total 348658128110406

More than 82% of the subjects with severe ED had a poor or very poor diabetic control, as compared to 48 % of the normal subjects [Table/Fig-5]. These pointed to a direct correlation between degrees of glycaemic control status, as was assessed by HbA1c and degree of ED which were assessed by IIEF-5 (p-value 0.00799 - Significant).

Glycemic Control status as assessed by HbA1c

A correlation between Body Mass Index and severity of ED, as was assessed by IIEF, was seen (p-value 0.01960-Significant) [Table/Fig-6]. Probably the study population did not have a high proportion of morbid obese patients. A majority of patients were however overweight or Grade 1 obese.

Severity of IIEF and Body Mass Index

Severity IIEFG3G2G1OverweightNormalLean
Severe 492(4)3(6.1)4(8.1)25(51)12(24.5)3(6.1)
Moderate 911(1)5(5.4)25(27.4)39(42.8)15(16.4)6(6.5)
Mild 1291(.8)7(5.4)19(14.7)71(55)29(22.4)2(1.5)
Normal 79-5(6.3)21(26.6)28(35.4)24(30.4)1(1.2)
Total 348420691638012

In this study 57.1% of the subjects with severe ED had associated Hypertension, whereas about 36.7% subjects with no ED had hypertension [Table/Fig-7]. This could be because severe ED was seen in older subset of patients who had suffered from diabetes for long durations (p-value 0.05415 - Not Significant).

Severity of ED associated with Hypertension

Severity IIEFYesNo
Severe 4928(57.1)21(42.9)
Moderate 9147(51.6)44(48.4)
Mild 12954(41.8)75(58.1)
Normal 7929(36.7)50(63.2)

Discussion

An abridged, 5-item version of The International Index of Erectile Function IIEF-5, also known as the Sexual Health Inventory for Men (SHIM), as an inventory for diagnosis of ED, has not been commonly used in Indian patients and its use by patients may be helpful for them in being more forthcoming about the problem of ED.

In study of Kumar et al., [1] done in southern India, the prevalence of ED was reported to be 58%. Also, 94% of subjects with ED had an unsatisfactory blood sugar control (HbA1c>7%). Viswanathan et al., [2] reported that 44.4% of diabetic patients had sexual dysfunction, and that severe ED was associated with duration of diabetes, a poor glycaemic control and high blood pressure.

Neurological deficit, as is assessed by VPT, is an important parameter which is correlated with severity of ED. The results of present study were consistent with findings of Amano T et al., [3], where measurement of VPT was considered to be a simple and a useful indicator for diagnosing ED in DM patients. In multiple regression analysis, age and VPT were considered as independent risk factors for predicting ED in DM patients.

In study of Viswanathan et al., [2] done in south India, it was seen that 44.4% of diabetic patients had sexual dysfunction. They found that severe ED was associated with longer durations of diabetes, a poor glycaemic control and high blood pressure. Amano T et al., [3] also concluded that severity of ED in diabetic patients depended on duration of DM.

In study of Kumar et al., [1] done in southern India, increase in age to above 45 years was found to significantly increase the prevalence of ED.E L Rhoden et al., [4] observed a high rate of severe degree and a decrease in frequency of mild degree of ED with aging. Ponholzer A et al., [5] concluded that age was an important risk factor for ED. Severe ED (IIEF-5 score 5-7) increased from 0.4% (20-30 years) to 0.5% (41-50 years), 1.3% (51-60 years) and to 9.6% in those who were aged 71-80 years in this study. Miyata Y et al., [6] also identified aging as an independent factor in both ED and severe ED.

In a study done by Weinberg AE et al., [7], a poor glycaemic control, impaired insulin sensitivity, and the metabolic syndrome were associated with a heightened risk of ED. Glycaemic control is independently and inversely associated with ED in men with diabetes type 2, as was concluded by Awad H et al., [8]. Domenico Fedelea et al., [9], in which they quoted various studies that had re stressed that a poor metabolic control was associated with an increased risk of ED, both in Type 1 and Type 2 subjects. This underlined the possible benefit of glycaemic control in the prevention of ED. Viswanathan et al., [2] found that severe ED was associated with duration of diabetes, a poor glycaemic control and high blood pressure.

Giugliano F et al., [10] also pointed that among subjects with type 2 diabetes, glycaemic control and other metabolic covariates were associated with a risk for ED. Duration of diabetes and HbA1c levels have been pointed out by Meena BL [11] and Al-Hunayan A as increased risk factors for ED [12]. Lu CC et al., [13] reported that a better glycaemic control would probably reduce the prevalence of ED and its severity among younger men with type 2 DM.

Viswanathan et al., [2] Al-Hunayan A et al., [12] and Veronelli A et al., [14] have all reported that increased BMI had an association with a higher incidence of ED. This same result was reported by Tamler R. et al., [15] In a study done by Viswanathan et al., [2] it was found severe ED was associated with high blood pressure. Giuliano FA [16], as well as Ponholzer A [5], Al-Hunayan A [12], have all reported that patients with hypertension had a high prevalence of bothersome, untreated ED. Tomohode Yamada et al., [17] have reported that ED was associated with an increased risk of CV events in diabetic patients. Fiona Jamieson et al., [18], by using multi-variate analysis, have also found a significant association with hypertension.

Conclusion

In the present study, it was concluded that ED had significant association with age (p-value 0.00740), duration of diabetes (p-value 0.00034), glycaemic control with ED (p-value 0.00799) and BMI (p Value 0.01960), as was assessed by studying HbA1c levels. In fact, VPT emerged as a strongest predictor of prevalence of severe ED, as was assessed by studying IIEF-5 scores (p-value 0.00004). However, in this study, hypertension did not seem to have any strong predictive value (p-value 0.05415 - Insignificant). We conclude that adding objectivity of VPT measurement improves the subjective predictive value of IIEF-5.

References

[1]Kumar KV, Radhakrishnan AP, Nair V, Kumar H, Erectile Dysfunction in Diabetic Men Int Journal Diabetes Developing Countries 2004 :24  [Google Scholar]

[2]Viswanathan Vijay, Aggarwal Sarweswar, Kumpatla Satyavani, Severity of Erectile Dysfunction and Prevalence of Premature Ejaculation Among Type2 Diabetic Men Referred to an ED Clinic of a Tertiary Care Center JAPI August 2009 :57  [Google Scholar]

[3]Amano T, Imao T, Seki M, Takemae K, Ohta Y, Sakai S, Ohta H, The usefulness of vibration perception threshold as a significant indicator for erectile dysfunction in patients with diabetes mellitus at a primary diabetes mellitus clinic Urol Int 2011 87(3):336-40.  [Google Scholar]

[4]Rhoden EL, Telöken C, Sogari P R, Souto C A Vargas, The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction International Journal of impotence Research 2002 14:245-50.  [Google Scholar]

[5]Ponholzer A, Temml C, Mock K, Marszalek M, Obermayr R, Madersbacher S, Prevalence and risk factors for erectile dysfunction in 2869 men using a validated questionnaire Eur Urol 2005 Jan 47(1):80-5.discussion 85-6  [Google Scholar]

[6]Miyata Y, Shindo K, Matsuya F, Noguchi M, Nishikido M, Koga S, Erectile dysfunction in hemodialysis patients with diabetes mellitus: association with age and hemoglobin A1c levels Int J Urol 2004 Jul 11(7):530-4.  [Google Scholar]

[7]Weinberg AE, Eisenberg M, Patel CJ, Chertow GM, Leppert JT, Diabetes Severity, Metabolic Syndrome, and the Risk of Erectile Dysfunction J Sex Med 2013 Sep 9 10(12):3102-09.  [Google Scholar]

[8]Awad H, Salem A, Gadalla A, El Wafa NA, Mohamed OA, Erectile function in men with diabetes type 2:correlation with glycemic control Int J Impot Res 2010 Jan-Feb 22(1):36-9.  [Google Scholar]

[9]Domenico Fedelea, Angela Bortolottib, Carlo Coscellic, Fausto Santeusaniod, Liliane Chatenoudb, Enrico Collie, Erectile dysfunction in Type 1 and Type 2 diabetics in Italy International Journal of Epidemiology 2009 29:524-31.  [Google Scholar]

[10]Giugliano F, Maiorino M, Bellastella G, Gicchino M, Giugliano D, Esposito K, Determinants of erectile dysfunction in type 2 diabetes Int J Impot Res 2010 May-Jun 22(3):204-9.  [Google Scholar]

[11]Meena BL, Kochar DK, Agarwal TD, Choudhary R, Kochar A, Association between erectile dysfunction and cardiovascular risk in individuals with type-2 diabetes without overt cardiovascular disease Int J Diabetes Dev Ctries 2009 Oct 29(4):150-4.  [Google Scholar]

[12]Al-Hunayan A, Al-Mutar M, Kehinde EO, Thalib L, Al-Ghorory M, The prevalence and predictors of erectile dysfunction in men with newly diagnosed with type 2 diabetes mellitus BJU Int 2007 Jan 99(1):130-4.  [Google Scholar]

[13]Lu CC, Jiann BP, Sun CC, Lam HC, Chu CH, Lee JK, Association of glycemic control with risk of erectile dysfunction in men with type 2 diabetes J Sex Med 2009 Jun 6(6):1719-28.  [Google Scholar]

[14]Veronelli A, Masu A, Ranieri R, Rognoni C, Laneri M, Pontiroli AE, Prevalence of erectile dysfunction in thyroid disorders: comparison with control subjects and with obese and diabetic patients Int J Impot Res 2006 Jan-Feb 18(1):111-4.  [Google Scholar]

[15]Tamler R, Diabetes, obesity and erectile dysfunction Gend Med 2009 6(Suppl 1):4-16.  [Google Scholar]

[16]Giuliano ED FA, Leriche A, Jaudinot EO, de Gendre AS, Prevalence of erectile dysfunction among 7689 patients with diabetes or hypertension, or both Urology 2004 Dec 64(6):1196-201.  [Google Scholar]

[17]Tomohide Yamada, Kazuo Hara, Hitomi Umematsu, Ryo Suzuki, Takashi Kadowaki, Erectile Dysfunction and Cardiovascular Events in Diabetic Men: A Meta-analysis of Observational Studies PLOS ONE September 2012 7(9)  [Google Scholar]

[18]Jamieson Fiona, Chalmers John, Duncan Catriona, Prescott Robin J, Campbell Ian W, Erectile dysfunction in type 1 diabetic males British Journal of Diabetes and Vascular Disease 2008 8:232  [Google Scholar]